MTOS Technology is actively seeking strategic partnerships for technology transfer
MTOS-V is a safe analgesic new drug that provides significant analgesic effect without dependence or gastrointestinal injury.
✔ Relieves certain cancer-related pain and may serve as a substitute for morphine-based analgesics
✔ Relieves toothache and severe pain caused by viral infection of intercostal nerves and herpes zoster
✔ Relieves pain caused by trauma
✔ Relieves pain caused by burns, scalds, etc.
✔ Free of dependence & gastrointestinal injury
Animal pharmacodynamic tests showed that MTOS-V significantly promotes the production of interleukin 4 (P < 0.001), which then stimulates endogenous analgesic substances (enkephalin) to relieve pain.
Analgesic effects were observed in models of hot plate pain, visceral pain, and tail-press pain, lasting 2-3 hours.
Combination of internal and external administration enhances the effect, ensuring quick onset (10 minutes) and prolonged analgesia.